Efficacy and safety of anlotinib combined with TACE among patients with intermediate and advanced-stage hepatocellular carcinoma (HCC)

被引：2
|
作者：
Zheng, Lin [1 ]
Li, Hailiang [1 ]
Guo, Chenyang [1 ]
Hu, Hongtao [1 ]
Li, Fangkun [1 ]
机构：
[1] Zhengzhou Univ, Affiliated Canc Hosp, Dept Minimal Invas Intervent, Zhengzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.454
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
454
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy and safety of TACE combined with anlotinib compared with TACE alone among patients with intermediate or advanced hepatocellular carcinoma (HCC): A randomized, controlled, phase II clinical study.
    Zeng, Hui
    Shao, Guoliang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 581 - 581
  • [2] Efficacy and safety of donafenib combined with transarterial chemoembolization (TACE) for treating intermediate/advanced-stage hepatocellular carcinoma (HCC): A retrospective real-world study
    Wei, Ning
    Lu, Dong
    Xiao, Jingkun
    Zhou, Chunze
    Zhang, Xingming
    Xu, Shaobao
    Zhang, Zhengfeng
    Cheng, Delei
    Shi, Changsheng
    Liu, Kaicai
    Gao, Zonggen
    Zhu, Yijiang
    Chu, Senlin
    Yin, Liang
    Su, Mingxue
    Lv, Weifu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA (HCC): TO TACE OR NOT TO TACE?
    Farinati, F.
    Giacomin, A.
    Tartaro, P.
    Vanin, V.
    Sergio, A.
    Burra, P.
    Cillo, U.
    Di Nolfo, M. A.
    Del Poggio, P.
    Benvegnu, L.
    Zoli, M.
    Borzio, F.
    Giannini, E. G.
    Caturelli, E.
    Trevisani, F.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S288 - S289
  • [4] Investigation of the Difference of Efficacy and Safety of TACE Combined with Sintilimab and Bevacizumab versus TACE Combined with Donafenib in Patients with Intermediate or Advanced Hepatocellular Carcinoma
    Sun, Yanjun
    Wang, Xing
    Ling, Changchun
    Yu, Yong
    Jia, Pengfei
    Lu, Xiaohua
    Zhao, Hui
    Gu, Zhuxin
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S412 - S412
  • [5] A retrospective study on the efficacy and safety of donafenib combined with transarterial chemoembolization (TACE) and with/without immunotherapy in intermediate-advanced hepatocellular carcinoma (HCC).
    Chen, Cong
    Fu, Shouzhong
    Zhao, Suming
    Yuan, Hongxin
    Dai, Feng
    Gu, Weiwei
    Gu, Zhuxin
    Shi, Rongfeng
    Yang, Xiaohu
    Lu, Xiaohua
    Jia, Pengfei
    Si, Luyi
    Zhao, Hui
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] The safety and efficacy of TACE combined with apatinib on patients with advanced hepatocellular carcinoma: a retrospective study
    Yang, Zeran
    Chen, Guang
    Cui, Ye
    Xiao, Guowen
    Su, Tianhao
    Yu, Jianan
    Zhang, Zhiyuan
    Han, Yanjing
    Yang, Kailan
    Jin, Long
    [J]. CANCER BIOLOGY & THERAPY, 2019, 20 (03) : 321 - 327
  • [7] Efficacy Of Apatinib In Transcatheter Arterial Chemoembolization (TACE) Refractory Intermediate And Advanced-Stage Hepatocellular carcinoma: A Propensity Score Matching Analysis
    Qiu, Zhiyu
    Shen, Lujun
    Chen, Shuanggang
    Qi, Han
    Cao, Fei
    Xie, Lin
    Fan, Weijun
    [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9321 - 9330
  • [8] Original Comparison of efficacy and safety between transarterial chemoembolization (TACE) combined with lenvatinib versus TACE combined with sorafenib in the treatment of intermediate and advanced hepatocellular carcinoma
    Xu, Rui
    Ji, Xuebing
    Pei, Xiaohong
    Yu, Yongqiang
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (02): : 1117 - 1128
  • [9] Efficacy and safety of transarterial chemoembolization alone compared to its combination with anlotinib among patients with intermediate or advanced stage hepatocellular carcinoma: a phase II randomized controlled trial
    Zhang, Dinghu
    Zhang, Zhewei
    Luo, Jun
    Zheng, Jiaping
    Mao, Xiaochun
    Tsilimigras, Diamantis I.
    Chun, Ho Jong
    Zeng, Hui
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (04) : 1627 - 1635
  • [10] Efficacy and safety of subsequent radiotherapy in patients with advanced-stage hepatocellular carcinoma treated with immune checkpoint inhibitors
    Ning, Cong
    Jia, Jun
    Zhang, Xinmu
    Sun, Jing
    Wang, Yunchao
    Xue, Jingnan
    Zhang, Longhao
    Hou, Xiaorong
    Yang, Xiaobo
    Sang, Xinting
    Duan, Xuezhang
    Zhao, Haitao
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2023, 12 (06) : 882 - 898
12345